Oct 20, 2023, 20:13
Aman Chauhan: We will continue to work on NEC and SCLC and hopefully find a breakthrough
Aman Chauhan, Leader of Neuroendocrine Cancer Program at the Sylvester Comprehensive Cancer Center, shared on his Twitter:
“High-grade NEC is among the toughest cancers to treat. I had a great time collaborating with Dr. Anish Thomas and help in accrual for this ATRi study. Please check out our work just published in JAMA Oncology. We will continue to work on NEC and SCLC and hopefully find a breakthrough. Promising studies on the horizon. Stay tuned!! ”
For the article click here.
Source: Aman Chauhan/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 12:18
Dec 21, 2024, 11:52
Dec 21, 2024, 11:30
Dec 21, 2024, 11:25
Dec 21, 2024, 11:18